Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug-induced endocrine blood pressure elevation
Katharina R. Beck, George R. Thompson, Alex Odermatt
Pharmacological Research (2019) Vol. 154, pp. 104311-104311
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Drug‐induced peripheral oedema: An aetiology‐based review
Bérenger Largeau, Jean‐Luc Cracowski, Céline Lengellé, et al.
British Journal of Clinical Pharmacology (2021) Vol. 87, Iss. 8, pp. 3043-3055
Open Access | Times Cited: 60
High extracellular ATP levels released through pannexin-1 channels mediate inflammation and insulin resistance in skeletal muscle fibres of diet-induced obese mice
Gonzalo Jorquera, Roberto Meneses‐Valdés, Giovanni Rosales‐Soto, et al.
Diabetologia (2021) Vol. 64, Iss. 6, pp. 1389-1401
Open Access | Times Cited: 34
Molecular mechanisms of posaconazole- and itraconazole-induced pseudohyperaldosteronism and assessment of other systemically used azole antifungals
Katharina R. Beck, Lucija Telisman, Chris J. van Koppen, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2020) Vol. 199, pp. 105605-105605
Closed Access | Times Cited: 38
Blood Pressure–Elevating and Antihypertensive Medication Prescription Trends
Ashutosh Kumar, Nicole L. Therrien, John I. Ogwuegbu, et al.
Hypertension (2025)
Closed Access
Steroid Hormones in Pain: Mechanistic Underpinnings and Therapeutic Perspectives
Xinying Zhang, Xiaolin Yang, Yawei Ji, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2025) Vol. 251, pp. 106769-106769
Closed Access
Antifungal therapy with azoles and the syndrome of acquired mineralocorticoid excess
Katharina R. Beck, Alex Odermatt
Molecular and Cellular Endocrinology (2021) Vol. 524, pp. 111168-111168
Open Access | Times Cited: 18
Species-specific differences in the inhibition of 11β-hydroxysteroid dehydrogenase 2 by itraconazole and posaconazole
Silvia G. Inderbinen, Michael Zogg, Manuel Kley, et al.
Toxicology and Applied Pharmacology (2020) Vol. 412, pp. 115387-115387
Open Access | Times Cited: 17
A Physiologically Based Pharmacokinetic and Pharmacodynamic Model of the CYP3A4 Substrate Felodipine for Drug–Drug Interaction Modeling
Laura Maria Fuhr, Fatima Zahra Marok, Maximilian Mees, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1474-1474
Open Access | Times Cited: 11
Assessment of the potential risk of oteseconazole and two other tetrazole antifungals to inhibit adrenal steroidogenesis and peripheral metabolism of corticosteroids
Marie-Christin Jäger, Víctor González‐Ruiz, F. Joos, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Gynecomastia and hypertension in a patient treated with posaconazole
George R. Thompson, Prasanth Surampudi, Alex Odermatt
Clinical Case Reports (2020) Vol. 8, Iss. 12, pp. 3157-3160
Open Access | Times Cited: 9
Modulation of 11β-hydroxysteroid dehydrogenase functions by the cloud of endogenous metabolites in a local microenvironment: The glycyrrhetinic acid-like factor (GALF) hypothesis
David J. Morris, Andrew S. Brem, Alex Odermatt
The Journal of Steroid Biochemistry and Molecular Biology (2021) Vol. 214, pp. 105988-105988
Open Access | Times Cited: 8
Characterization of the interferences of systemic azole antifungal drugs with adrenal steroid biosynthesis using H295R cells and enzyme activity assays
Marie-Christin Jäger, F. Joos, Denise V. Winter, et al.
Current Research in Toxicology (2023) Vol. 5, pp. 100119-100119
Open Access | Times Cited: 3
Reducing the off-target endocrinologic adverse effects of azole antifungals—can it be done?
Matthew I. Balcerek, Adam G. Stewart, Paul R. Chapman, et al.
International Journal of Antimicrobial Agents (2022) Vol. 59, Iss. 5, pp. 106587-106587
Closed Access | Times Cited: 5
Pseudohyperaldosteroism during itraconazole treatment: a hitherto neglected clinically significant side effect
S Brandi, Claus Larsen Feltoft, Jørgen Serup, et al.
BMJ Case Reports (2021) Vol. 14, Iss. 6, pp. e243191-e243191
Open Access | Times Cited: 6
Metyrapone in Cushing’s syndrome: a profile of its use
Zaina T. Al-Salama
Drugs & Therapy Perspectives (2021) Vol. 37, Iss. 9, pp. 393-406
Open Access | Times Cited: 6
Virtual screening and biological evaluation to identify pharmaceuticals potentially causing hypertension and hypokalemia by inhibiting steroid 11β-hydroxylase
Marie-Christin Jäger, Jacek Kędzierski, Victoria Gell, et al.
Toxicology and Applied Pharmacology (2023) Vol. 475, pp. 116638-116638
Open Access | Times Cited: 2
Successful Treatment of Paecilomyces variotii Pneumonia and Lupus Nephritis With Posaconazole-Cyclophosphamide Co-administration Without Drug Interaction–Induced Toxicity
Joseph Pechacek, Taura Webb, Elise M. N. Ferré, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 1
In silico and in vitro assessment of drugs potentially causing adverse effects by inhibiting CYP17A1
Jacek Kędzierski, Marie-Christin Jäger, Sadaf Naeem, et al.
Toxicology and Applied Pharmacology (2024) Vol. 486, pp. 116945-116945
Open Access
Roselle (
Behdad Dehkhoda, Ayesheh Enayati, Hassan Mirzaei, et al.
PubMed (2024) Vol. 14, Iss. 4, pp. 505-519
Closed Access
Trends in Prescription Fills for Blood Pressure-Elevating and Antihypertensive Medications, 2017-2023
Ashutosh Kumar, Nicole L. Therrien, John I. Ogwuegbu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Data science-driven analyses of drugs inducing hypertension as an adverse effect
Reetu Sharma
Molecular Diversity (2020) Vol. 25, Iss. 2, pp. 801-810
Closed Access | Times Cited: 2
Evaluation of Hypertension
Jordana B. Cohen, Raymond R. Townsend
Nephrology Self-Assessment Program (2020) Vol. 19, Iss. 1, pp. 8-19
Closed Access | Times Cited: 2
Pseudohyperaldosteroism during itraconazole treatment: a hitherto neglected clinically significant side effect
S Brandi, Claus Larsen Feltoft, Jørgen Serup, et al.
Drug and Therapeutics Bulletin (2022) Vol. 61, Iss. 3, pp. 44-47
Closed Access | Times Cited: 1
Lavender (Lavandula angustifolia) syrup as an adjunct to standard care in patients with mild to moderate COVID-19: An open-label, randomized, controlled clinical trial.
Marzieh Qaraaty, Mohsen Bahrami, Sadegh-Ali Azimi, et al.
PubMed (2023) Vol. 13, Iss. 4, pp. 400-411
Closed Access
P16-24: In silico and in vitro workflow to identify pharmaceuticals inhibiting CYP17A1 and CYP11B1
Marie-Christin Jäger, Jacek Kędzierski, Victoria Gell, et al.
Toxicology Letters (2023) Vol. 384, pp. S194-S195
Closed Access
Page 1 - Next Page

Scroll to top